-
July 1, 2022 Psychedelic Business Spotlight – July 1This week in psychedelic stock news: MindMed downplays delisiting fears; Red Light Holland teams with...
-
March 23, 2022 Ketamine Study Suggests the Psychedelic Could Treat Parkinson’s DiseasePharmaTher evaluates safety, tolerability and efficacy of low-dose ketamine infusion for treatment of LID in...
-
December 17, 2021 Psychedelic Business Spotlight – December 17This week in psychedelic business news: Cybin steps closer to a new patent; MindMed appoints...
-
December 3, 2021 Psychedelic Business Spotlight: December 3This week in psychedelic business news: MAPS pioneers new funding structure; FDA green lights a...
-
November 26, 2021 Psychedelic Business Spotlight: November 26This week in psychedelic business news: Compass Pathways files another patent; Seelos Therapeutics raises big...
-
November 24, 2021 PharmaTher Believes Ketamine Could Treat This Rare Neurological ConditionThe company is also exploring if ketamine can treat other neurological conditions, including Parkinson’s Disease,...
-
November 12, 2021 Psychedelic Business Spotlight: November 12This week in psychedelic business news: two of the biggest players in the industry unveil...
-
November 5, 2021 Psychedelic Business Spotlight: November 5This week in psychedelic business news: DEA grants Cybin a Schedule I manufacturing license; PharmaTher...
-
October 15, 2021 Psychedelic Business Spotlight: October 15This week in psychedelic business news: Cybin inhales; atai Life Sciences expands; DEA grants new...
-
October 13, 2021 FDA Backs Ketamine to Treat This Rare and Debilitating Pain SyndromeFood and Drug Administration grants psychedelic biotechnology company PharmaTher orphan drug designation for ketamine to...
